Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 8950940Search this ID in NIH RePORTER
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.
FY2026 award categories
- Pathology
NIH Funding · FY2024
Linked Award Amount
$1.8M
Full award amounts, FY2024
Award Records
4
Records listing this PI
Award-Linked Rank
#6,620
By linked amount among FY2024 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2024 award records by amount
NIH award records listing Qing Zhang as a PI. Multi-PI records show the full award amount for context.
- 1R01CA294636-01R01New Von Hippel Lindau (VHL) tumor suppressor signaling in renal cancer$546.3Kaward amount
- 5R01CA284591-02R01Identification of DCLK2-TBK1 signaling axis as a potential therapeutic target in kidney cancer$446.3Kaward amount
- 5R01CA274924-02R01A New Histone H3 Modification Regulates Epigenetic Programming and Gene Expression in Breast Cancer$406.3Kaward amount
- 5R01CA256833-04R01BBOX1 is a Novel Oncogenic Driver in Triple Negative Breast Cancer$375.3Kaward amount
Award organization
Organizations that administered FY2024 awards listing Qing Zhang as a PI.
FY2024 award administered by UT Southwestern Medical Center (TX).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardUT Southwestern Medical Center
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #6620
- 2025$2M Cumulative Funding
- 2025R01 Grant Holder
- 2026$5M Cumulative Funding
- 2026Entered Top 25% NationallyRanked #2042